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Noroviruses (NoVs) are responsible for the majority of gastroenteritis outbreaks in humans. Recently, NoV
strains which are genetically closely related to human genogroup II (GII) NoVs have been detected in fecal
specimens from swine. These findings have raised concern about the possible role of pigs as reservoirs for NoVs
that could infect humans. To better understand the epidemiology of swine NoVs in both the swine and the
human populations, rapid immunoassays are needed. In this study, baculovirus recombinants were generated
to express the capsid gene of a swine NoV GII genotype 11 (GII.11) strain which self-assembled into virus-like
particles (VLPs). Subsequently, the purified VLPs were used to evoke monoclonal antibodies (MAbs) in mice.
A panel of eight promising MAbs was obtained and evaluated for their ability to bind to heterologous VLPs,
denaturated antigens, and truncated capsid proteins. The MAbs could be classified into two groups: two MAbs
that recognized linear epitopes located at the amino-terminal half (shell domain) of the swine NoV GII.11 VLPs
and that cross-reacted with human GII.4 NoV VLPs. The other six MAbs bound to conformational epitopes and
did not cross-react with the human GII.4 VLPs. To our knowledge, this is the first report on the character-
ization of MAbs against swine NoVs. The swine NoV VLPs and the MAbs described here may be further used
for the design of diagnostic reagents that could help increase our knowledge of the prevalence of NoV infections
in pigs and the possible role of pigs as reservoirs for NoVs.
Caliciviruses cause a variety of diseases in humans and an-
imals. Members of this family are small, nonenveloped icosa-
hedral viruses with a nonsegmented, positive-sense, poly-
adenylated RNA genome (22). The genome is 7.3 to 8.3 kb
long and has two or three open reading frames (ORFs) that
encode a polyprotein that undergoes protease processing to
produce several nonstructural proteins, including an RNA-
dependent RNA polymerase. The major capsid protein (VP1)
and a minor capsid protein (VP2) are encoded by ORF1 and
ORF2, respectively (in the genera Lagovirus and Sapovirus), or
by ORF2 and ORF3, respectively (in the genera Vesivirus and
Norovirus). On the basis of phylogenetic variation and genome
organization, the family Caliciviridae has been divided into
four distinct genera: Norovirus, Sapovirus, Vesivirus, and Lago-
virus. Two new genera have been proposed for viruses infecting
calves and rhesus monkeys, respectively (19, 46, 56).
Noroviruses (NoVs) are a widespread cause of nonbacterial
gastroenteritis. In humans, NoVs are considered the major
cause of acute gastroenteritis in adults and have been identi-
fied as the cause of approximately half of all gastroenteritis
outbreaks worldwide (for recent reviews, see references 1, 17,
62, and 70). On the basis of the phylogenetic analysis of the
capsid gene, NoVs have been classified into five genogroups
(genogroup I [GI] to GV) that are further subdivided into 8,
19, 2, 2, and 1 genotypes, respectively (43, 68, 77). NoVs in-
fecting humans fall into GI, GII, and GIV, with viruses in GII
being the most prevalent (21). In fact, strains belonging to GII
genotype 4 (GII.4) have accounted for the great majority of
NoV outbreaks worldwide during the last decade (8, 36, 41).
NoVs have also been described in animals (for reviews, see
references 54 and 67). Bovine and murine NoVs are classified
separately into GIII and GV, respectively, while swine NoVs
are grouped into at least three genotypes (GII.11, GII.18, and
GII.19) together with human strains into GII (68). Recently, a
lion NoV related to GIV NoVs has been reported (43).
The first methods of finding NoV in animals were based on
oligonucleotide primers targeting human NoVs and yielded
low prevalence values (60, 66). More recent studies with more
specific and sensitive detection reagents have shown that NoVs
are frequent in husbandry animals worldwide (14, 18, 48, 49,
53, 65, 68, 73). The existence of animal NoVs is relevant in
several ways. (i) As in humans, infections can cause enteric
disease in farm animals, resulting in economic losses for the
livestock industry (25, 54, 72). (ii) Animals could be infected by
and act as reservoirs for human NoVs. Conversely, animal
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NoVs could be zoonotic and could infect humans. In addition,
homologous recombination between the human NoV and the
animal NoV genomes could give rise to variants with com-
pletely new pathogenic and host tropism characteristics. These
concerns are especially important for swine NoVs, since they
are very closely related genetically to the most prevalent (GII)
human NoVs. (iii) Animal NoVs could provide a much needed
animal model for the study of the pathogenesis of NoV and
immune responses to NoV. The swine model of NoV infection
would make an excellent candidate, considering the physiolog-
ical and immunological similarities between the human and the
pig species (57, 58).
With the exception of the recently discovered mouse strains,
NoVs cannot be easily grown in cell culture (16), although a
complex three-dimensional system for the culture of human
NoVs has recently been described (59). In early studies, NoVs
had to be obtained from fecal specimens from experimentally
infected human volunteers (64). A major breakthrough in NoV
research was the finding that when VP1 of Norwalk virus (the
prototypic strain of the genus Norovirus) was expressed in
insect cells and other recombinant systems, it self-assembled
into virus-like particles (VLPs) that are morphologically and
antigenically identical to the native viral particle (24, 31). Sub-
sequently, VP1 from a number of different human and animal
NoV genotypes have been expressed in insect cells (4, 15, 23,
26, 30, 32, 39).
On the basis of the X-ray crystallographic structure of Nor-
walk virus, capsids are composed of 90 dimers of VP1 and
exhibit T  3 icosahedral symmetry (52). Each VP1 monomer
(530 amino acids [aa]) contains a short N-terminal region (aa
1 to 49), followed by a shell (S) domain (aa 50 to 225) and a
protruding (P) domain that can be divided into two subdo-
mains: P1 (aa 226 to 278 and 406 to 520) and P2 (aa 279 to
405). The N-terminal/shell (N/S) domain forms the inner core
of the capsid and is the most conserved part of VP1, while the
P domain forms the protruding arches of the capsid and is
more diverse. The P2 subdomain, which is located at the sur-
face of the capsid, contains the highest degree of variability in
the genome among NoV strains. It contains the determinants
of strain specificity, receptor binding (11, 63), and potential
neutralizing antibody recognition sites (10, 40).
In this paper, we describe the cloning and expression of recom-
binant GII.11 swine NoV VLPs, the use of these VLPs to obtain
swine NoV-specific monoclonal antibodies (MAbs), and the pri-
mary characterization of these antibodies. To our knowledge, this
is the first report of MAbs against a swine NoV.
MATERIALS AND METHODS
Viruses and cells. Derivatives of Autographa californica nuclear polyhedrosis
virus containing the full-length capsid protein gene of swine NoV strain SwVA34
(Sw/NV/VA34/1998/NL; GenBank accession no. AY077644) (66), the different
fragments of the gene (the N/S, P, and P2 domains), and the full-length capsid
protein gene of a human NoV from a GII.4 strain (Ast6139/01/Sp; GenBank
accession no. AJ583672) (5) were propagated in insect cell lines grown in sus-
pension or monolayer cultures at 28°C in TNM-FH medium (Sigma) supple-
mented with 5% fetal calf serum (Gibco). Spodoptera frugiperda (SF9) cells were
used for the generation of recombinant baculoviruses, plaque assays, and the
preparation of high-titer viral stocks. Trichoplusia ni (H5) cells were used for the
high-level expression of recombinant proteins.
RT-PCR cloning of swine NoV capsid nucleotide sequences. The swine GII.11
NoV strain Sw/NoV/34/1998/NET (SwVA34) was obtained from fecal samples as
part of a surveillance study in The Netherlands and has already been described
(66). To amplify a 3-kb reverse transcription-PCR (RT-PCR) product that in-
cludes the VP1 major capsid protein, 2.5 l of SWVA34 RNA was reverse
transcribed with 200 U of Superscript III (Invitrogen) and primer (T)25VN (37).
RNA was removed from the RNA-DNA hybrids by treatment with RNase H for
20 min at 37°C. Long template PCR was performed with primer swine POL fw
(Table 1) and primer (T)25VN by using Phusion high-fidelity DNA polymerase
(Finnzymes, Espoo, Finland), according to the manufacturer’s instructions.
The 3-kb products were excised from the agarose gel with UV light from a
Dark Reader (Clare Chemical Research Inc., Dolores, CO), cloned by using a
TA cloning kit (Invitrogen, Leek, Netherlands), and sequenced by using an ABI
Prism BigDye Terminator cycle sequencing reaction kit (Perkin-Elmer, Nieu-
werkerk a/d IJssel, The Netherlands) on an automated sequencer (model 377;
Applied Biosystems, Nieuwerkerk a/d IJssel, Netherlands). From a total of 10
colonies picked, seven clones had an insert of the expected size. Four of these
clones were sequenced, and one clone (clone pSw1POL_CAP) with a nucleotide
sequence that exactly matched the ORF2 sequence of strain SwVA34 reported
previously (GenBank accession no. AY077644) was selected for the subsequent
construction of the recombinant baculovirus.
Cloning of the swine NoV full-length capsid gene and different gene fragments
into baculovirus transfer vector. The baculovirus transfer vector chosen for
expression of the swine NoV capsid protein was plasmid pBacPAK8XB (2). The
primers used for PCR amplification are summarized in Table 1. The full-length
capsid gene of SwVA34 was subcloned in pBacPAK8XB by using the cloned
cDNA (pSw1POL_CAP) as the template for PCR and primer pair swNV-F and
swNV-R. After PCR amplification and digestion with BglII, the capsid gene
sequence was cloned into the unique BglII restriction site in plasmid
pBacPAK8XB, resulting in plasmid pSwNV1.
The gene fragments containing the N/S domain (aa 1 to 216), the P domain (aa
217 to 547), and the P2 subdomain (aa 275 to 425) of the SwVA34 capsid protein
were subcloned in pBacPAK8XB by using plasmid pSwNV1 as the template for
the PCRs, resulting in plasmids pSwNV-NS, pSwNV-P, and pSwNV-P2, respec-
tively. The primer pairs used were swNV-F and swNVS-R to amplify the N/S
construct, SwNVP-F and SwNVP-R to amplify the P construct, and SwNVP2-F
and SwNVP2R to amplify the P2 construct. The amplified DNA fragments were
digested with the BglII and KpnI restriction enzymes and were inserted into
pBacPAK8XB. All the inserted sequences in the resulting recombinant plasmids
were verified by sequence analyses.
Generation of recombinant baculoviruses. All recombinant baculoviruses
were produced with the BacPAK baculovirus expression system (Clontech), as
described previously (2). Briefly, monolayers of SF9 insect cells were cotrans-
fected with recombinant transfer vectors and Bsu36I triple-cut A. californica
nuclear polyhedrosis virus DNA (35) by using lipofectamine (Invitrogen). Re-
combinant baculoviruses were selected on the basis of their LacZ-negative phe-
notypes, plaque purified, and propagated as described elsewhere (33).
Expression and purification of the recombinant swine NoV VLPs. H5 insect
cell monolayers were infected with the recombinant baculovirus at a multiplicity
of infection of 10. After incubation (6 to 7 days, 28°C), the infected cells were
scraped into the medium. The culture medium was then clarified by centrifuga-
tion (at 10,000 rpm for 10 min with a GSA rotor), and the supernatant was
TABLE 1. Oligonucleotides used for cloning
Oligonucleotide
name Sequence (5–3)
a
Swine POL fw.................TGGTGATTTCCGCATCTCTA
swNV-F............................AAATAGATCTATAAATATGAAGATGG
CGTCTAATGACGCTTCC
swNV-R ...........................GGTACCAGATCTCAACGAACTCTCCT
GCGCCCACTGCC
swNVS-R.........................CAACGGTACCTCACACCAGAAA-CATA
AACTCAAAGTC
SwNVP-F.........................TAGAAGATCTATAAATATGAAGCCCC
CCACTGTTGAGTCTAAAAC
SwNVP-R........................GTACGGTACCTCAACGAACTCTCCTG
CGCC
SwNVP2-F.......................ATAGAGATCTATAAATATGAAGACCA
CACAGCTTGTGTCTTG
SwNVP2R .......................TCACGGTACCTCAAAGG-TTGGTGTTG
TTCG
a Restriction site sequences are underlined. Start and stop codons are shown
in boldface.
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centrifuged at 26,000 rpm for 2 h with a Beckman SW28 rotor. The pelleted
material was resuspended in 0.2 M phosphate-buffered saline (PBS; 0.2 M so-
dium phosphate, 0.1 M NaCl, pH 6.0) for VLPs (PBS-V), extracted twice with
Vertrel XF extraction buffer, and subjected to centrifugation (at 35,000 rpm for
2 h with a Beckman SW55 rotor) through a 20% sucrose cushion of 1.5 ml made
with PBS-V. Subsequently, the pellet was suspended in a solution of CsCl (0.42
g/ml) and subjected to isopycnic gradient centrifugation at 35,000 rpm for 18 h
in a Beckman SW55 rotor. The visible opalescent band in the CsCl gradient was
collected by micropipetting, diluted in PBS-V, and pelleted by centrifugation at
26,000 rpm for 2 h in a Sorvall TH-641 rotor to remove CsCl. The pellet was
finally resuspended in PBS-V containing protease inhibitors (Complete; Roche)
and stored at 4°C. The protein concentrations of the VLP preparations were
determined with a bicinchoninic acid protein assay kit (Pierce).
Electron microscopy. Samples (approximately 5 l) were applied to glow-
discharged carbon-coated grids for 2 min. and negatively stained with 2% (wt/
vol) aqueous uranyl acetate. Micrographs were recorded with a Jeol 1200 EXII
electron microscope operating at 100 kV at a nominal magnification of 40,000.
Sequence analysis. The amino acid sequences of the complete capsid protein and
the N/S and P domains of swine NoV strain SwVA34 were compared with those of
swine and human NoV strains representative of the different genotypes of GII. The
classification and the GenBank accession numbers of the NoVs strains are listed in
Table 2. The capsid subdomains were determined on the basis of previously reported
data (52). The Basic Local Alignment Search Tool (BLAST; http://www.ncbi.nlm
.nih.gov/BLAST) was used to find homologous hits. Multiple-sequence alignment
was performed with the ClustalW program (http://npsa-pbil.ibcp.fr/cgi-bin/npsa
_automat.pl?page  /NPSA/npsa_clustalw.html) (12).
TABLE 2. Amino acid sequence identities within VP1 protein of SwVA34 with sequences within VP1 proteins of representative NoV strains
of the different GII genotypes
Genotype Strain GenBankaccession no.
Capsid
length (aa)
% Amino acid sequence identity
VP1 N/S domain P domain
GII.11 SwVA34 AY077644 547 100.0 100.0 100.0
SwK5/JP AB221132 547 98.0 99.5 96.9
Sw43 AB074892 547 97.6 98.6 96.9
QW48 AY823303 547 97.1 99.1 95.7
Sw918 AB074893 547 96.5 98.6 95.1
GII.19 QW170 AY823306 548 81.3 90.5 75.1
QW218 AY823307 548 81.3 90.5 75.1
GII.3 G5175/AUS DQ379713 548 71.3 81.4 64.5
Toronto U02030 548 70.8 81.0 63.9
Mexico U22498 548 70.4 80.5 63.6
Arg320 AF190817 548 70.4 81.9 62.7
GII.6 Miami/292 AF414410 547 70.6 82.8 62.4
SU17-JPN AB039779 547 70.4 82.8 62.1
Baltimore AF414408 550 69.9 82.3 62.0
GII.18 QW101 AY823304 557 69.4 81.9 60.5
QW125 AY823305 557 69.2 81.9 60.2
GII.14 M7 AY130761 536 67.5 82.8 57.5
GII.8 Amsterdam AF195848 537 67.5 81.9 58.0
GII.17 CSE1 AY502009 540 67.4 77.8 60.5
GII.7 Leeds AJ277608 540 66.5 81.9 56.8
GII.10 Erfurt AF427118 548 66.4 80.5 57.1
GII.2 Melksham X81879 542 66.4 80.1 57.2
GII.12 Chitta AB032758 535 66.4 76.9 59.9
GII.1 Hawaii U07611 535 66.2 77.8 58.4
GII.5 Hillingdon AJ277607 540 66.1 80.1 57.0
GII.9 VA97207 AY038599 537 66.1 81.4 55.3
GII.4 Bristol X76716 539 64.7 79.6 54.7
GII.16 Tiffin AY502010 540 64.6 77.8 55.8
GII.13 Fayetteville AY113106 542 63.2 76.5 54.0
GII.15 J23 AY130762 555 60.6 75.8 50.6
GI.1 Norwalk M87661 530 44.7 56.9 36.7
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Production of MAbs. To produce MAbs, four female BALB/c mice were
inoculated intraperitoneally with 50 g of purified swine NoV VLPs in complete
Freund’s adjuvant. The animals were 5 weeks old at the time of the first inocu-
lation. After that, the mice were boosted twice, at 3-week intervals, with 50 g of
purified VLPs in incomplete Freund’s adjuvant. After the second boost, sera
were collected from the tail vein and checked for antibodies specific for swine
NoV capsid protein by enzyme-linked immunosorbent assay (ELISA). The two
mice with higher antibody titers were further immunized twice with purified
VLPs and no adjuvant 5 and 3 days, respectively, before they were sacrificed.
Hybridomas were obtained by fusion of splenocytes with myeloma SP2 cells in
the presence of polyethylene glycol, as described elsewhere (6, 20). The super-
natants of the individual hybridoma clones were screened by ELISA. Superna-
tants that recognized purified VLPs but that did not react with extracts from
wild-type (wt) baculovirus-infected H5 insect cells were selected. All positive
hybridomas were subcloned at least twice before expansion.
The Mouse Typer isotyping panel from Bio-Rad Laboratories was used to
determine the immunoglobulin (Ig) isotypes of the MAbs, and the conditions
recommended by the manufacturer were used.
ELISA. ELISA plates (Polysorp; Nunc, Rosklide, Denmark) were coated with
0.1 g/well of purified VLPs (swine NoV or human GII.4 VLPs) diluted in 0.05
M carbonate-bicarbonate buffer (pH 9.6) and incubated overnight at 4°C. The
plates were blocked with PBS–5% skim milk for 2 h at 37°C, washed five times
with PBS-0.05% Tween 20 (PBS-T), and incubated with serial dilutions of the
hybridoma supernatants. Each hybridoma supernatant sample was analyzed in
parallel in a well lacking antigen to determine the level of background binding.
After several washes with PBS-T, the plates were incubated at 37°C for 1 h with
horseradish peroxidase-conjugated goat anti-mouse Ig (Bio-Rad) at a 1/1,000
dilution. Finally, the plates were extensively washed with PBS-T and the color
reaction was developed with the peroxidase substrate (4 mg/ml o-phenylenedi-
amine and 0.08% H2O2 [30%] in 0.05 M phosphate-citrate buffer [pH 5.0]). The
reaction was stopped by addition of 3 N H2SO4, and color development was
recorded at 492 nm. The reaction of a supernatant sample with the antigen was
considered positive when the absorbance value was over threefold the back-
ground level (the absorbance of the well lacking antigen).
SDS-PAGE and Western blot analyses. Samples were boiled for 5 min in
protein dissociation buffer containing 5% (vol/vol) -mercaptoethanol, 2% (wt/
vol) sodium dodecyl sulfate (SDS), 10% (vol/vol) glycerol, 80 mM Tris-HCl (pH
6.8), and 0.01% (wt/vol) bromophenol blue. Proteins were resolved by SDS-
polyacrylamide gel electrophoresis (PAGE) and were visualized by Coomassie
brilliant blue staining.
For Western blot analyses, proteins were transferred from gels onto poly-
vinylidene difluoride membranes by standard blotting procedures. The mem-
branes were saturated (overnight, 4°C) with PBS–5% (wt/vol) nonfat dry milk
and incubated (1 h, 37°C) with the primary antibody, as indicated. After several
washes with PBS-T, the membranes were incubated (1 h, 37°C) with horseradish
peroxidase-conjugated goat anti-mouse Ig (Bio-Rad). The membranes were
washed extensively with PBS-T and developed with the peroxidase substrate
(0.05% 4-chloro-1-naphthol, 0.08% H2O2 [30%], and 20% methanol in PBS).
Flow cytometry. H5 insect cells were infected with the indicated recombinant
baculoviruses. Three days postinfection, the cells were detached and fixed for 15
min in 10% formalin (Sigma). For labeling of the cells, the cells were permeab-
ilized in PBS-T for 10 min. The cells were then incubated for 1 h at 4°C with
hybridoma supernatant diluted 1:5 in PBS-T. After three washes with PBS-T the
cells were incubated for 30 min at 4°C in PBS-T containing R-phycoerythrin-
conjugated anti-mouse antibody (Dako) at a 1:100 dilution. After three washes,
the labeled cells were analyzed by flow cytometry with a FACScallibur cytometer
and CellQuest software.
RESULTS
Construction and expression of swine NoV recombinant
VLPs. The full-length capsid protein gene derived from a swine
NoV strain, strain SwVA34, collected in The Netherlands (66)
was cloned into a baculovirus transfer vector, which was then
used to obtain recombinant baculovirus SwNV1, which ex-
pressed the swine NoV VP1 protein. Cultures of H5 insect cells
were infected with wt or SwNV1 baculovirus to analyze the
expression of the recombinant protein. A major polypeptide
band with the expected molecular mass of 60 kDa was iden-
tified in lysates of SwNV1-infected H5 cells after analysis by
SDS–10% PAGE and staining with Coomassie blue (Fig. 1A).
To determine whether the recombinant swine NoV VP1 was
able to assemble into VLPs, supernatants from infected H5 cell
cultures were subjected to CsCl-gradient centrifugation and
were characterized by electron microscopy. Negatively stained
fractions enriched in the swine NoV VP1 (Fig. 1B, inset) re-
vealed VLPs that were morphologically similar to authentic
NoV virions (Fig. 1B) and that were approximately 40 nm in
diameter (18).
Sequence comparison. The amino acid identities of the pre-
dicted complete, N/S, and P domains of the capsid protein of
porcine NoV strain SwVA34 with other reported porcine
NoVs and representative human NoV strains of GII are sum-
marized in Table 2. On the basis of phylogenetic analysis of the
complete VP1 amino acid sequence, strain SwVA34 shared
96.5 to 98% amino acid identity with other porcine strains of
GII.11 (strains SwK5/JP, Sw43, and QW48), including proto-
type strain Sw918 (61), and 81.3% amino acid identity with
porcine strains of GII.19 (strains QW170 and QW218). The
human strains most closely related to strain SwVA34 belonged
to GII.3 (70.4 to 71.3% amino acid identities) and GII.6 (69.9
to 70.6% amino acid identities). The amino acid identities to
porcine NoV strains of GII.18 (strains QW101 and QW125)
ranged from 69.2 to 69.4%. The amino acid identity with the
Bristol strain, the prototype strain of GII.4, which is responsi-
ble for the majority of human NoV outbreaks worldwide, was
64.7%. Within GII, the lowest amino acid identity (60.6%) was
observed with the human NoV strain of GII.15. Comparison of
the amino acid identities of the N/S and P domains showed
similar relationships. The amino acid identities of the N/S
domain of SwVA34 with the N/S domains of NoV strains of
different GII genotypes ranged from 75.8 to 99.5%, and the
amino acid identities of the P domain ranged from 50.6 to
96.9%.
Production of swine NoV-specific MAbs. Purified, recombi-
nant SwVA34 VLPs were used to immunize mice and obtain
swine NoV-specific MAbs, as described in Materials and Meth-
FIG. 1. Expression of swine NoV VLPs. (A) H5 cells were infected
with wt or SwNV1 recombinant baculovirus, and equal amounts of
infected cell lysates were analyzed by SDS–10% PAGE and Coomassie
blue staining. Molecular weight markers (MW; in 103 Da) are given on
the left. (B) Electron microscopy of negatively stained purified swine
NoV VLPs. Purified particles were analyzed for protein content by
SDS–10% PAGE and stained with Coomassie brilliant blue (inset).
Scale bar, 100 nm.
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ods. After the hybridoma cell lines were screened, eight posi-
tive hybridoma cell lines derived from two different immunized
mice were selected. The eight MAbs obtained were deter-
mined to be isotype IgG1. A summary of the characteristics of
the eight MAbs described in this paper is shown in Table 3.
Specificities of the MAbs. To analyze the specificities and
cross-reactivities of the MAbs, we performed ELISAs in which
serial dilutions of the hybridoma supernatants were assayed
against different baculovirus-expressed recombinant VLPs. As
expected, none of the MAbs reacted with extracts of mock-
infected or wt baculovirus-infected H5 insect cells (data not
shown). The eight MAbs reacted strongly with SwVA34 VLPs
(Fig. 2A, upper panel). In addition, two of the MAbs (MAbs
SwNV3A10 and SwNV6E11) recognized heterologous VLPs
derived from a Spanish NoV strain (strain Ast6139/01/Sp)
grouped in GII.4 (5), although the reactivities of both MAbs to
the heterologous VLPs were clearly lower than the reactivity
exhibited against SwVA34 VLPs (Fig. 2A, lower panel). None
of the MAbs showed any reactivity against VLPs derived from
rabbit hemorrhagic disease virus (genus Lagovirus) (2) or fe-
line calicivirus (genus Vesivirus) (data not shown).
To further characterize the nature of the epitopes recog-
nized by the MAbs, we analyzed their reactivities in Western
blots. The two MAbs shown to cross-react with GII.4 VLPs
(MAbs SwNV3A10 and SwNV6E11) by ELISA also reacted in
Western blot assays with both the SwVA34 and the GII.4 VLPs
(Fig. 2B). This result indicates that these MAbs recognize
linear epitopes of the NoV capsid protein. The other six MAbs
did not recognize SwVA34 or GII.4 VLPs in Western blot
assays (data not shown), suggesting that these MAbs recognize
conformational epitopes.
In agreement with the results mentioned above, we found
that MAbs SwNV3A10 and SwNV6E11 reacted strongly in
ELISAs against the denatured SwVA34 capsid protein
(treated with 8 M urea), while the other six MAbs did not
recognize the denatured capsid protein in ELISAs (data not
shown).
Physical mapping of the epitopes recognized by the MAbs.
In order to localize the regions of the capsid protein recog-
nized by the MAbs, we prepared three additional recombinant
baculoviruses that expressed the N/S domain (aa 1 to 216), the
P domain (aa 217 to 547), and the P2 subdomain (aa 275 to
425) of the strain SwVA34 VP1 protein, respectively. Expres-
sion of recombinant polypeptides of the expected sizes was
confirmed by SDS–12% PAGE analysis (Fig. 3A). The recom-
binant proteins were recognized by an SwVA34 VLP-specific
rabbit polyclonal antiserum by ELISA and Western blotting
(data not shown). The P domain was expressed at high levels,
similar to those exhibited by the full-length capsid protein,
whereas the N/S and P2 domains were expressed at notably
lower levels.
Cell extracts prepared from H5 insect cell cultures that had
been infected with the recombinant baculoviruses expressing
the different VP1 protein fragments were assayed by indirect
ELISA and Western blotting with the MAbs. The two cross-
reactive MAbs, MAbs SwNV3A10 and SwNV6E11, reacted
strongly with the full-length VP1 protein and the N/S truncated
FIG. 2. (A) Reactivities of the MAbs with SwVA34 and human
GII.4 (HuGII.4) NoV VLPs. The wells of ELISA plates were coated
with equal amounts of purified SwVA34 or human GII.4 VLPs, and
serial dilutions (threefold) of the eight hybridoma cell culture super-
natants were used to detect antigens (OD, optical density). (B) Reac-
tivities by Western blotting of MAbs SwNV3A10 and SwNV6E11
against SwVA34 and human GII.4 capsid proteins. Purified VLPs were
resolved by SDS–10% PAGE and transferred to membranes which
were reacted with the indicated hybridoma cell culture supernatants.
Molecular weight markers (MW; in 103 Da) are given on the left.
TABLE 3. Reactivities of the eight swine NoV-specific MAbs
MAb namea
Reactivity
SwVA34
VLPsb
SwVA34
VLPsc
GII.4
VLPsd
N/S
domaine
P
domaine
P2
domaine
SwNV3A10      
SwNV6E11      
SwNV2C1      
SwNV6C9      
SwNV8C12      
SwNV8E12      
SwNV8F10      
SwNV8B10      
a All MAbs were of the IgG1 isotype.
b Recognition of the swine NoV VLPs of strain SwVA34 by ELISA.
c Recognition of the swine NoV VLPs of strain SwVA34 by Western blotting.
d Recognition of the human NoV VLPs of GII.4 (strain Ast6139/01/Sp) by
ELISA.
e Recognition of the N/S, P, or P2 domain of the SwVA34 capsid protein by
ELISA.
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protein by both ELISA (Table 3) and Western blotting assays.
Figure 3B shows the reactivity of MAb SwNV3A10 with the
swine NoV VP1 protein fragments in Western blots and shows
that the reactivity was identical to that of MAb SwNV6E11
(data not shown). This result indicates that the epitopes rec-
ognized by these MAbs localize within the first 216 aa of the
SwVA34 capsid protein. In contrast, the other six MAbs,
shown to recognize conformational epitopes, recognized only
the full-length VP1 protein in ELISAs and did not react with
any of the truncated versions of the SwVA34 capsid protein
(Table 3).
Finally, the specificities of the MAbs were further confirmed
by flow cytometry. H5 insect cells were infected with wt or
recombinant baculoviruses expressing SwVA34 VLPs, GII.4
VLPs, and the truncated versions of the SwVA34 capsid pro-
tein. Fixed cells were labeled with the MAbs and were analyzed
by flow cytometry. The results obtained precisely matched our
ELISA and Western blot assay results (Table 3). Figure 4
shows the results obtained with MAbs SwNV2C1 and
SwNV3A10, representative of the two patterns of reactivity
exhibited by the panel of MAbs specific for the swine NoV
capsid protein reported in this study.
DISCUSSION
In this study, we expressed swine NoV capsid proteins in a
baculovirus expression system and used the recombinant VLPs
to generate and evaluate a panel of MAbs.
Of the eight MAbs selected, MAbs SwNV3A10 and
SwNV6E11 recognized linear epitopes in the conserved N/S
domain of swine NoV VP1 and cross-reacted with VLPs de-
rived from an NoV strain of GII.4, which is the genotype
responsible for the majority of NoV outbreaks in humans (36).
The six other MAbs recognized conformational epitopes and
did not cross-react with GII.4 VLPs.
The epitopes recognized by the non-cross-reactive MAbs
could not be mapped to the N/S, P, or P2 domain because they
did not recognize any of the truncated forms of recombinant
VP1 protein expressed. One possible explanation for this lack
of reactivity is that the conformational epitopes recognized by
these MAbs are not correctly expressed in the truncated ver-
sions of the recombinant capsid protein. Another possibility is
that the MAbs recognize epitopes made up of sequences from
both the N/S and the P domains or from two adjacent capsid
monomers so that none of the truncated proteins contains the
mature epitopes. Further studies of these MAbs will be nec-
essary to understand the exact locations of these epitopes.
Several groups have reported MAbs against human, bovine,
and murine NoVs (28, 29, 34, 47, 64, 71, 75, 76) which have
FIG. 3. (A) Analysis of MAb SwNV3A10 binding to the fragments
of VP1. H5 cells were infected with recombinant baculoviruses ex-
pressing the swine NoV full-length VP1 or the protein domains: N/S,
P, and P2. Equal amounts of infected cell lysates were analyzed by
SDS–12% PAGE and Coomassie blue staining. Arrows indicate the
positions of the recombinant polypeptides N/S and P2. Molecular
weight markers (MW; in 103 Da) are given on the left. (B) Reactivity
in Western blots of MAb SwNV3A10 against the VP1 fragments.
Infected cell lysates were resolved by SDS–12% PAGE and transferred
to membranes, which were reacted with the hybridoma cell culture
supernatant of MAb SwNV3A10. Molecular weight markers (MW; in
103 Da) are given on the left.
FIG. 4. Reactivities of MAbs SwNV3A10 and SwNV2C1 by flow cytometry. H5 insect cells infected with recombinant baculoviruses expressing
the indicated NoV capsid proteins were incubated with hybridoma cell culture supernatants plus a R-phycoerythrin-conjugated anti-mouse
antibody and analyzed by flow cytometry. The dashed line corresponds to the results for cells infected with wt baculovirus. HuGII.4, human GII.4.
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been mapped to different regions of the VP1 protein. MAbs
recognizing epitopes in the exposed P2 subdomain have been
shown to neutralize murine NoV infection (38), and MAbs to
GI.1 and GII.2 reference strains NV and Snow Mountain virus,
respectively, blocked the binding of VLPs to CaCo-2 cells and
inhibited hemagglutination (40). The epitope recognized by
one of these antibodies (MAb 61.21) contained amino acids
that are completely conserved among the various genogroups
of NoV strains, including strains isolated from swine, bovine,
and murine species (40). However, this MAb did not react to
representative strains of GI and GII, including strains
Southampton (GI.2), Desert Shield (GI.3), Toronto (GII.3),
and Lordsdale (GII.4) (40).
Broadly reactive MAbs are of special interest, as they could
be used for the development of simple, rapid, diagnostic assays
for the detection of NoVs, including new previously unknown
NoV strains, in epidemiological studies. Several NoV-specific
MAbs exhibiting broad cross-reactivity (both intra- and in-
tergenogroup cross-reactivity) have been described (3, 27, 34,
47, 55, 75), and the epitopes recognized by some of them have
been precisely mapped to locations within the conserved N/S
domain (3, 47, 74) or the C-terminal part of the P1 subdomain
(50, 55, 75). However, none of these MAbs were tested with
swine NoVs strains, and given the amino acid sequence diver-
sity observed in the minimal binding regions reported for these
MAbs, their reactivities with swine NoVs strains (of GII.11,
GII.18, and GII.19) may not be readily anticipated (data not
shown), although some of them would likely recognize swine
strains.
In this respect, MAbs SwNV3A10 and SwNV6E11 seem
promising. Since swine NoV strain VA34 (GII.11) and human
strains of GII.4 are among the most divergent within GII
(Table 2), we speculate that these MAbs might recognize
NoVs belonging to most of the other genotypes of GII and
could also recognize NoVs of other genogroups, as is the case
for other MAbs which bind to epitopes located at the N/S
domain (3, 47, 74). Work is in progress to further characterize
the range of NoV strains that are recognized by these MAbs,
with the focus on their usefulness as broad-range diagnostic
reagents for NoV detection. On the other hand, MAbs specific
for swine NoV strains would also constitute useful reagents. In
follow-up studies, we will analyze the reactivity of our panel of
MAbs with swine NoV strains of GII.18 and GII.19.
The fact that swine NoVs are genetically closely related to
strains infecting humans has raised concerns about the possi-
bility that these viruses might be able to cross the species
barrier (18, 42, 66, 68, 69), which may result in a disease more
serious than that typically associated with NoV infection (45).
Recombination between NoVs of different genotypes within
GII has been reported (7, 51). Although it has not yet been
reported, homologous recombination between swine and hu-
man NoV genomes could lead to new variants with altered
tropisms and virulence characteristics. Recent findings indicate
that such events could happen because (i) seroprevalence stud-
ies have shown that pigs’ sera contain antibodies against hu-
man NoVs (18); (ii) human GII.4 NoVs can infect piglets
experimentally (9) and human GII NoV genomic sequences
have been detected in the manure of pigs (44); and (iii) sur-
veillance studies with bivalve mollusks, a common source of
food-borne NoV gastroenteritis, have demonstrated the simul-
taneous presence of both human and swine NoVs (13), leading
to concerns about the risk of coinfection with human and
animal NoV strains.
In summary, the relevance of NoV infections to human health,
the close genetic relationship between human and swine NoV
strains, and the prevalence of NoVs in swine highlight the need
for the comprehensive surveillance of NoVs in pigs. The swine
NoV VLPs and the MAbs reported in this study might eventually
be used in diagnostic assays that could help increase our knowl-
edge of the prevalence of NoV infections in pigs and the possible
role of pigs as reservoirs for NoVs infecting humans.
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